| 1 |
Yogendra C. Shah |
Interdigital Patent Holdings |
12 |
| 2 |
Jinsheng Chen |
Johnson & Johnson |
8 |
| 3 |
Matthew L. Ward |
Trueposition |
5 |
| #4 |
Todd Rimmer |
Intel |
3 |
| #5 |
Brian Dec |
Depuy Synthes Products |
2 |
| #5 |
Rosario S. Calio |
Veltek Associates |
2 |
| #5 |
Colin J. Kling |
RTX (Raytheon) |
2 |
| #5 |
Timothy A. Ringeisen |
Kensey Nash |
2 |
| #5 |
Michael S. Saporito |
Melior Pharmaceuticals I |
2 |
| #5 |
Peter Fatone |
Depuy Synthes Products |
2 |
| #5 |
Andrew G. Reaume |
Melior Pharmaceuticals I |
2 |
| #5 |
Adam K. Fontecchio |
Delos Living |
2 |
| #5 |
Hong Lin |
Prelude Therapeutics, Incorporated |
2 |
| #14 |
Robert Gorkin |
Dublin City University |
1 |
| #14 |
Mitch Thompson |
Two Guys And A Hat |
1 |
| #14 |
Danny R. Gaydou |
Rovi Guides |
1 |
| #14 |
Magid A. Abou-Gharbia |
Amerimas Home Products |
1 |
| #14 |
Mladen Tomich |
Medimmune Limited |
1 |
| #14 |
Jason A. Carpenter |
Graco Children'S Products |
1 |
| #14 |
Wei Liu |
Pfizer |
1 |
| #14 |
Lauren Shafer Burgess |
Medimop Medical Projects |
1 |
| #14 |
Jerome E. Toth |
Thermal |
1 |
| #14 |
Chris Wendt |
Comcast |
1 |
| #14 |
John Ciallella |
Melior Pharmaceuticals I |
1 |
| #14 |
John Gruner |
Melior Pharmaceuticals I |
1 |
| #14 |
Peter H. D. Glenn |
Music Choice |
1 |
| #14 |
Kangtai Ren |
Dsm Ip Assets B.V. |
1 |
| #14 |
Yu-Kai Lee |
Johnson & Johnson |
1 |
| #14 |
Noel J. Pixley |
Puricore |
1 |
| #14 |
Stephen Heiman |
Depuy Synthes Products |
1 |
| #14 |
Nalin Subasinghe |
3-Dimensional Pharmaceuticals |
1 |
| #14 |
Geoffrey Richard Koontz |
Puricore |
1 |
| #14 |
Heather Hain |
— |
1 |
| #14 |
Jerry Holway |
Unknown |
1 |
| #14 |
Craig Kashuba |
K2M |
1 |
| #14 |
Ismael Palacios Nieto |
University Of Alabama |
1 |
| #14 |
Daryl J. Clark |
Jet Medical |
1 |
| #14 |
James Pressler |
Siemens Aktiengesellschaft |
1 |
| #14 |
Krishnaraj Tejeswi |
Miller Edge |
1 |
| #14 |
Neil Jacobson |
Outotec (Finland) Oy |
1 |
| #14 |
Tianqi Gao |
Federal-Mogul Powertrain |
1 |
| #14 |
Jennifer Elizabeth Antoline Al-Rashid |
Dsm Ip Assets B.V. |
1 |